Balance Sheet Insights: Bausch Health Companies Inc (BHC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios

Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

In the latest session, Bausch Health Companies Inc (NYSE: BHC) closed at $8.78 down -3.83% from its previous closing price of $9.13. In other words, the price has decreased by -$3.83 from its previous closing price. On the day, 1.4 million shares were traded. BHC stock price reached its highest trading level at $9.12 during the session, while it also had its lowest trading level at $8.765.

Ratios:

For a deeper understanding of Bausch Health Companies Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.02 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.35. For the most recent quarter (mrq), Quick Ratio is recorded 0.82 and its Current Ratio is at 1.19.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on August 02, 2024, Downgraded its rating to Underweight and sets its target price to $3 from $9 previously.

On July 10, 2024, Raymond James started tracking the stock assigning a Mkt Perform rating and target price of $8.

Jefferies Upgraded its Hold to Buy on September 20, 2023, whereas the target price for the stock was revised from $9 to $16.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 06 ’24 when Carson Seana sold 13,370 shares for $6.21 per share. The transaction valued at 83,028 led to the insider holds 435,198 shares of the business.

Carson Seana bought 13,370 shares of BHC for $83,028 on Sep 06 ’24. On Mar 04 ’24, another insider, Carson Seana, who serves as the EVP, General Counsel of the company, sold 6,313 shares for $9.80 each. As a result, the insider received 61,867 and left with 499,905 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 3370826240 and an Enterprise Value of 24949313536. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.48. Its current Enterprise Value per Revenue stands at 2.633 whereas that against EBITDA is 8.129.

Stock Price History:

Over the past 52 weeks, BHC has reached a high of $11.46, while it has fallen to a 52-week low of $3.96. The 50-Day Moving Average of the stock is 8.60%, while the 200-Day Moving Average is calculated to be 13.93%.

Shares Statistics:

For the past three months, BHC has traded an average of 2.15M shares per day and 2878790 over the past ten days. A total of 365.24M shares are outstanding, with a floating share count of 325.07M. Insiders hold about 11.62% of the company’s shares, while institutions hold 74.74% stake in the company. Shares short for BHC as of 1730332800 were 11651014 with a Short Ratio of 5.60, compared to 1727654400 on 14784647. Therefore, it implies a Short% of Shares Outstanding of 11651014 and a Short% of Float of 3.4299999999999997.

Dividends & Splits

The stock’s 5-year Average Dividend Yield is 6.52.

Most Popular